[1] |
National Comprehensive Cancer Network: NCCN Breast Cancer Clinical Practice Guidelines in Oncology(Version 1. 2012)[EB/OL]. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. |
[2] |
Wilhelm AJ, Mijnhout GS, Franssen EJ. Radiopharmaceuticals in sentinel lymph-node detection-an overview[J]. Eur J Nucl Med, 1999, 26(4 Suppl):S36-42. |
[3] |
Michenfelder MM, Bartlett LJ, Mahoney DW, et al. Particle-size and radiochemical purity evaluations of filtered 99mTc-sulfur colloid prepared with different heating times[J]. J Nucl Med Technol, 2014, 42(4):283-288. DOI:10.2967/jnmt.114.145391. |
[4] |
李蕾, 张秀丽, 霍宗伟, 等. 99Tcm-硫胶体不同制备条件及注射部位对乳腺癌前哨淋巴结检出的影响[J].中华核医学与分子影像杂志, 2014, 34(4):296-300. DOI:10.3760/cma.j.issn.2095-2848.2014.04.007. Lei L, Zhang XL, Huo ZW, et al. Effects of different preparation methods and injection sites of 99Tcm-sulfur colloid on sentinel lymph node detection in breast cancer[J]. Chin J Nucl Med Mol Imaging, 2014, 34(4):296-300. doi: 10.3760/cma.j.issn.2095-2848.2014.04.007 |
[5] |
李囡, 林保和, 欧阳涛, 等. 99mTc-美罗华用于原发性乳腺癌前哨淋巴结活检[J].中国医学影像技术, 2009, 25(4):681-684. DOI:10.3321/j.issn:1003-3289.2009.04.047. Li N, Lin BH, Ouyang T, et al. Sentinel lymph node biopsy with a novel sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast cancer[J]. Chin J Med Imaging Technol, 2009, 25(4):681-684. doi: 10.3321/j.issn:1003-3289.2009.04.047 |
[6] |
Kameswaran M, Subramanian S, Pandey U, et al. Preliminary evaluation of the potential of 99mTc carbonyl-DTPA-Rituximab as a tracer for sentinel lymph node detection[J]. Appl Radiat Isot, 2016, 107:195-198. DOI:10.1016/j.apradiso.2015.10.025. |
[7] |
李艳, 李囡, 翟士桢, 等.特异性前哨淋巴结显像剂99Tcm-rituximab药盒的制备及生物评价[J].同位素, 2011, 24 suppl:S85-89. Li Y, Li N, Zhai SZ, et al. Preparation and evaluation of a freeze-dried Kit of 99Tcm-rituximab for sentinel lymph node imaging[J]. J Isot, 2011, 24 suppl:S85-89. |
[8] |
杨春慧, 李洪玉, 梁积新, 等. 99Tcm标记右旋糖苷衍生物的制备及其生物分布[J].同位素, 2012, 25(3):149-154. Yang CH, Li HY, Liang JX, et al. Preparation and biodistribution study of 99Tcm labelled dextran conjugates[J]. J Isot, 2012, 25(3):149-154. |
[9] |
Morais M, Campello MP, Xavier C, et al. Radiolabeled mannosylated dextran derivatives bearing an NIR-fluorophore for sentinel lymph node imaging[J]. Bioconjug Chem, 2014, 25(11):1963-1970. DOI:10.1021/bc500336a. |
[10] |
Surasi DS, O'Malley J, Bhambhvani P. 99mTc-Tilmanocept:A Novel Molecular Agent for Lymphatic Mapping and Sentinel Lymph Node Localization[J]. J Nucl Med Technol, 2015, 43(2):87-91. DOI:10.2967/jnmt.115.155960. |
[11] |
Van Den Berg NS, Buckle T, Kleinjan GI, et al. Hybrid tracers for sentinel node biopsy[J]. Q J Nucl Med Mol Imaging, 2014, 58(2):193-206. |
[12] |
Deininger RA, Lee JY. Comment on "An ATP-based method for monitoring the microbiological drinking water quality in a distribution network" by E. Delahaye et al., 2003. Water Res. 37, 3689-3696[J]. Water Res, 2005, 39(12):2778-2779. DOI:10.1016/j.watres.2005.04.030. |
[13] |
Sappey MPC. Anatomie, Physiologie, Pathologie des vaisseaux Lymphatiques consideres chez L'homme at les Vertebres[M]. Paris: A. Delahaye and E. Lecrosnier, 1874. |
[14] |
Tanis PJ, Nieweg OE, Valdes Olmos RA, et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy[J]. J Am Coll Surg, 2001, 192(3):399-409. DOI:10.1016/S1072-7515(00)00776-6. |
[15] |
Suami H, Pan WR, Mann GB, et al. The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy:a human cadaver study[J]. Ann Surg Oncol, 2008, 15(3):863-871. DOI:10.1245/s10434-007-9709-9. |
[16] |
Mudun A, Sanli Y, Ozmen V, et al. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer:single institution experience[J]. Clin Nucl Med, 2008, 33(4):262-267. DOI:10.1097/RLU.0b013e3181662fc7. |
[17] |
邱鹏飞, 刘雁冰, 赵荣荣, 等.乳腺癌内乳区前哨淋巴结显像新技术[J].中华肿瘤杂志, 2013, 35(11):858-862. DOI:10.3760/cma.j.issn.0253-3766.2013.11.013. Qiu PF, Liu YB, Zhao RR, et al. A novel technique for scintigraphic visualization of internal mammary sentinel lymph nodes in breast cancer patients[J]. Chin J Oncol, 2013, 35(11):858-862. doi: 10.3760/cma.j.issn.0253-3766.2013.11.013 |
[18] |
Sadeghi R, Asadi M, Treglia G, et al. Axillary concordance between superficial and deep sentinel node mapping material injections in breast cancer patients:systematic review and meta-analysis of the literature[J]. Breast Cancer Res Treat, 2014, 144(2):213-222. DOI:10.1007/s10549-014-2866-1. |
[19] |
贺青卿, 姜军, 杨新华, 等.乳腺癌淋巴引流途径的临床研究[J].中华乳腺病杂志:电子版, 2008, 2(2):140-148. DOI:10.3969/j.issn.1674-0807.2008.02.004. He QQ, Jiang J, Yang XH, et al. Clinical study on lymphatic drainage patterns of breast cancer[J]. Chin J Breast Dis(Electronic Version), 2008, 2(2):140-148. doi: 10.3969/j.issn.1674-0807.2008.02.004 |
[20] |
Madsen E, Gobardhan P, Bongers V, et al. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer[J]. Ann Surg Oncol, 2007, 14(4):1486-1492. DOI:10.1245/s10434-006-9230-6. |
[21] |
Sun X, Liu JJ, Wang YS, et al. Roles of preoperative lymphoscintigraphy for sentinel lymph node biopsy in breast cancer patients[J]. Jpn J Clin Oncol, 2010, 40(8):722-725. DOI:10.1093/jjco/hyq052. |
[22] |
Giammarile F, Alazraki N, Aarsvold JN, et al. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer[J]. Eur J Nucl Med Mol Imaging, 2013, 40(12):1932-1947. DOI:10.1007/s00259-013-2544-2. |